Castle Biosciences (CSTL) Competitors $28.90 +0.45 (+1.58%) (As of 12:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CSTL vs. FLGT, PSNL, MYGN, BDSX, GTH, VCYT, SGRY, LFST, CON, and PACSShould you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include Fulgent Genetics (FLGT), Personalis (PSNL), Myriad Genetics (MYGN), Biodesix (BDSX), Genetron (GTH), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and PACS Group (PACS). These companies are all part of the "medical" sector. Castle Biosciences vs. Fulgent Genetics Personalis Myriad Genetics Biodesix Genetron Veracyte Surgery Partners LifeStance Health Group Concentra Group Holdings Parent PACS Group Fulgent Genetics (NASDAQ:FLGT) and Castle Biosciences (NASDAQ:CSTL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations. Is FLGT or CSTL more profitable? Castle Biosciences has a net margin of 1.95% compared to Fulgent Genetics' net margin of -59.39%. Castle Biosciences' return on equity of 1.47% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Fulgent Genetics-59.39% -1.81% -1.66% Castle Biosciences 1.95%1.47%1.27% Do analysts recommend FLGT or CSTL? Fulgent Genetics presently has a consensus target price of $28.50, suggesting a potential upside of 64.93%. Castle Biosciences has a consensus target price of $37.88, suggesting a potential upside of 33.13%. Given Fulgent Genetics' higher probable upside, equities research analysts plainly believe Fulgent Genetics is more favorable than Castle Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fulgent Genetics 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Castle Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in FLGT or CSTL? 48.1% of Fulgent Genetics shares are owned by institutional investors. Comparatively, 92.6% of Castle Biosciences shares are owned by institutional investors. 31.8% of Fulgent Genetics shares are owned by insiders. Comparatively, 7.2% of Castle Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, FLGT or CSTL? Castle Biosciences has lower revenue, but higher earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than Castle Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFulgent Genetics$289.21M1.83-$167.82M-$5.52-3.13Castle Biosciences$219.79M3.63-$57.47M$0.20142.26 Does the media prefer FLGT or CSTL? In the previous week, Castle Biosciences had 4 more articles in the media than Fulgent Genetics. MarketBeat recorded 8 mentions for Castle Biosciences and 4 mentions for Fulgent Genetics. Castle Biosciences' average media sentiment score of 0.41 beat Fulgent Genetics' score of 0.36 indicating that Castle Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fulgent Genetics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Castle Biosciences 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor FLGT or CSTL? Fulgent Genetics received 154 more outperform votes than Castle Biosciences when rated by MarketBeat users. However, 64.75% of users gave Castle Biosciences an outperform vote while only 60.25% of users gave Fulgent Genetics an outperform vote. CompanyUnderperformOutperformFulgent GeneticsOutperform Votes24460.25% Underperform Votes16139.75% Castle BiosciencesOutperform Votes9064.75% Underperform Votes4935.25% Which has more volatility & risk, FLGT or CSTL? Fulgent Genetics has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500. Comparatively, Castle Biosciences has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. SummaryCastle Biosciences beats Fulgent Genetics on 13 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CSTL vs. The Competition Export to ExcelMetricCastle BiosciencesMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$796.88M$3.05B$5.05B$8.87BDividend YieldN/A11.09%4.97%4.06%P/E Ratio142.2611.1797.3414.18Price / Sales3.63208.381,218.4289.42Price / CashN/A376.8533.5132.79Price / Book1.964.905.805.12Net Income-$57.47M-$32.86M$119.07M$225.99M7 Day Performance-7.72%0.56%-1.83%-1.32%1 Month Performance-10.73%-0.22%-3.64%0.60%1 Year Performance46.80%26.01%31.62%26.23% Castle Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CSTLCastle Biosciences3.4881 of 5 stars$28.90+1.6%$37.88+31.1%+41.8%$809.49M$219.79M144.51540Insider TradeFLGTFulgent Genetics4.1615 of 5 stars$17.27-0.1%$28.50+65.0%-37.4%$528.29M$289.21M-3.131,184Analyst UpgradePSNLPersonalis4.2117 of 5 stars$3.40-1.7%$6.81+100.4%+156.3%$240.21M$73.48M0.00400MYGNMyriad Genetics4.2579 of 5 stars$15.33+0.2%$27.36+78.5%-15.3%$1.40B$753.20M0.002,700Analyst ForecastBDSXBiodesix2.6823 of 5 stars$1.21+1.3%$3.06+153.9%-16.2%$175.29M$49.09M0.00220Negative NewsGap DownHigh Trading VolumeGTHGenetronN/A$4.03+0.2%N/A+7.8%$127.43M$94.34M0.00993High Trading VolumeVCYTVeracyte4.1416 of 5 stars$39.67+1.2%$41.25+4.0%+50.5%$3.07B$361.05M-261.33790Analyst ForecastSGRYSurgery Partners3.0985 of 5 stars$22.51flat$38.71+72.0%-29.9%$2.86B$2.74B-46.9013,500Analyst ForecastLFSTLifeStance Health Group1.7849 of 5 stars$7.22flat$8.50+17.7%+16.5%$2.76B$1.06B0.009,325CONConcentra Group Holdings ParentN/A$21.42+0.8%$28.50+33.1%N/A$2.73B$1.84B0.0011,000PACSPACS Group4.0859 of 5 stars$16.92-1.9%$39.88+135.7%N/A$2.58B$3.11B0.0032,433Analyst Forecast Related Companies and Tools Related Companies Fulgent Genetics Alternatives Personalis Alternatives Myriad Genetics Alternatives Biodesix Alternatives Genetron Alternatives Veracyte Alternatives Surgery Partners Alternatives LifeStance Health Group Alternatives Concentra Group Holdings Parent Alternatives PACS Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CSTL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSTL Stock Alerts